Loading insider details...
Latest Form 4 (Nov 13, 2026): Grant/Award of 500,000 ENGN shares.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Nov 13, 2026 | enGene Therapeutics Inc. (ENGN) | Grant/Award | 500,000 | n/a |
| Aug 21, 2026 | Neumora Therapeutics, Inc. (NMRA) | Grant/Award | 375,000 | n/a |
| Jan 9, 2026 | Neumora Therapeutics, Inc. (NMRA) | Grant/Award | 750,000 | n/a |
| May 30, 2025 | Neumora Therapeutics, Inc. (NMRA) | Disposition to Issuer | 400,000 | n/a |
| Feb 18, 2025 | Neumora Therapeutics, Inc. (NMRA) | Grant/Award | 500,000 | n/a |
| Dec 12, 2023 | Neumora Therapeutics, Inc. (NMRA) | Grant/Award | 400,000 | n/a |